Role of Triglyceride to High Density Lipoprotein (TG/HDL) Ratio as A Marker of Insulin Resistance in Adults of Central India: A Narrative Review
DOI:
https://doi.org/10.55489/njcm.150420243789Keywords:
Insulin resistance, Central India, TG/HDL ratio, lipid abnormalitiesAbstract
One of the main risk factors for the onset of type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD) is insulin resistance (IR). But because there aren't many easy-to-use and trustworthy biomarkers or tests, the entity is frequently under diagnosed. The present review was performed with an aim to provide the available data regarding the role or efficacy of TG/HDL ratio as an indicator of IR in adults of central India, a region popular for high prevalence of T2DM and CVD. An extensive search of all materials related to the topic was carried out in the PubMed search engine. Relevant research articles focusing on use of TG/HDL as a marker of insulin resistance published in the period 2002 to 2023 were included in the review. A total of 33 articles were selected based upon their suitability with the current review objectives and analyzed. The review concludes that TG/HDL ratio is a simple, affordable, and feasible marker of IR that can be used in economically poor regions of the India or world for screening IR and risk stratification of T2DM and CVD in adults. However, more studies are needed in India and all over the world to validate this marker and its cut-off values.
References
Freeman AM, Acevedo LA, Pennings N. Insulin Resistance. 2023 Aug 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. PMID: 29939616.
Cordero A, Ezquerra EA. TG/HDL ratio as surrogate marker for insulin resistance. E-Journal-of-Cardiology-Practice [internet]. 2009;8(16). Available from: https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-8/TG-HDL-ratio-as-surrogate-marker-for-insulin-resistance.
Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol-Endocrinol Metab. 2008 Jan;294(1):E15-26. Doi: https://doi.org/10.1152/ajpendo.00645.2007 PMid:17957034
Mohan V. Why are Indians more prone to diabetes? J Assoc Physicians India. 2004 Jun;52:468-74. PMID: 15645957.
Das RR, Mangaraj M, Nayak S, Satapathy AK, Mahapatro S, Goyal JP. Prevalence of Insulin Resistance in Urban Indian School Children Who Are Overweight/Obese: A Cross-Sectional Study. Front Med. 2021;8:613594. Doi: https://doi.org/10.3389/fmed.2021.613594 PMid:33644095 PMCid:PMC7907002
Luhar S, Timæus IM, Jones R, Cunningham S, Patel SA, Kinra S, et al. Forecasting the prevalence of overweight and obesity in India to 2040. PloS One. 2020;15(2):e0229438. Doi: https://doi.org/10.1371/journal.pone.0229438 PMid:32092114 PMCid:PMC7039458
Mahadik SR, Deo SS, Mehtalia SD. Increased prevalence of metabolic syndrome in non-obese asian Indian-an urban-rural comparison. Metab Syndr Relat Disord. 2007 Jun;5(2):142-52. Doi: https://doi.org/10.1089/met.2006.0029 PMid:18370823
Ebrahim S, Kinra S, Bowen L, et al. The Effect of Rural-to-Urban Migration on Obesity and Diabetes in India: A Cross-Sectional Study. PLoS Med. 2010;7(4):e1000268. Doi: https://doi.org/10.1371/journal.pmed.1000268 PMid:20436961 PMCid:PMC2860494
Sharp P, Mohan V, Levy J, Mather H, Kohner E. Insulin Resistance in Patients of Asian Indian and European Origin with Non-Insulin Dependent Diabetes. Horm Metab Res. 1987;19(02):84-85. Doi: https://doi.org/10.1055/s-2007-1011745 PMid:3549505
Mohammadi R, Goodarzi-Khoigani M, Allameh Z, et al. Association between Socioeconomic Status and Homeostasis Model Assessment-Insulin Resistance Index and Mediating Variables at the First Trimester of Pregnancy. Iran J Nurs Midwifery Res. 2022;27(2):166-168. doi:10.4103/ijnmr.ijnmr_451_20
Silva FACCD, Bragança MLBM, Bettiol H, Cardoso VC, Barbieri MA, Silva AAMD. Socioeconomic status and cardiovascular risk factors in young adults: a cross-sectional analysis of a Brazilian birth cohort. Rev Bras Epidemiol. 2020;23:e200001. Doi: https://doi.org/10.1590/1980-549720200001 PMid:32130390
Che B, Zhong C, Zhang R, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol. 2023;22(1):34. Doi: https://doi.org/10.1186/s12933-023-01762-2 PMid:36797706 PMCid:PMC9936712
Deusdará R, De Moura Souza A, Szklo M. Association between Obesity, Overweight, Elevated Waist Circumference, and Insulin Resistance Markers among Brazilian Adolescent Students. Nutrients. 2022;14(17):3487. Doi: https://doi.org/10.3390/nu14173487 PMid:36079745 PMCid:PMC9458155
Ren X, Chen Zeng ai, Zheng S, et al. Association between Triglyceride to HDL-C Ratio (TG/HDL-C) and Insulin Resistance in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Ye J, ed. PLOS ONE. 2016;11(4):e0154345. Doi: https://doi.org/10.1371/journal.pone.0154345 PMid:27115999 PMCid:PMC4846162
Arslan B, Çobanoğlu İM, Dinçel AS. Status of lipid profile tests according to the last consensus paper. Turk J Biochem. 2020;45(3):337-338. Doi: https://doi.org/10.1515/tjb-2020-0172
Fan J, Liu Y, Yin S, et al. Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation. Nutr Metab. 2019;16(1):7. Doi: https://doi.org/10.1186/s12986-019-0334-y PMid:30679939 PMCid:PMC6341753
Nigam PK. Serum Lipid Profile: Fasting or Non-fasting? Indian J Clin Biochem. 2011;26(1):96-97. Doi: https://doi.org/10.1007/s12291-010-0095-x PMid:22211025 PMCid:PMC3068759
Jin X, Yang S, Lu J, Wu M. Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies. Front Cardiovasc Med. 2022;8:804214. Doi: https://doi.org/10.3389/fcvm.2021.804214 PMid:35224026 PMCid:PMC8866335
Park B, Jung DH, Lee HS, Lee YJ. Triglyceride to HDL-Cholesterol Ratio and the Incident Risk of Ischemic Heart Disease Among Koreans Without Diabetes: A Longitudinal Study Using National Health Insurance Data. Front Cardiovasc Med. 2021;8:716698. Doi: https://doi.org/10.3389/fcvm.2021.716698 PMid:34490378 PMCid:PMC8418107
Borrayo G. Tg/Hdl-C Ratio as Cardio-Metabolic Biomarker even in Normal Weight Women. Acta Endocrinol Buchar. 2018;14(2):261-267. Doi: https://doi.org/10.4183/aeb.2018.261 PMid:31149268 PMCid:PMC6516523
Gong R, Luo G, Wang M, Ma L, Sun S, Wei X. Associations between TG/HDL ratio and insulin resistance in the US population: a cross-sectional study. Endocr Connect. 2021;10(11):1502-1512. Doi: https://doi.org/10.1530/EC-21-0414 PMid:34678755 PMCid:PMC8630769
Chiang JK, Lai NS, Chang JK, Koo M. Predicting insulin resistance using the triglyceride-to-high-density lipoprotein cholesterol ratio in Taiwanese adults. Cardiovasc Diabetol. 2011;10(1):93. Doi: https://doi.org/10.1186/1475-2840-10-93 PMid:22004541 PMCid:PMC3224454
Martínez-Marroquín Y, Meaney A, Samaniego-Méndez V, et al. The TG/HDL-c Lipid Ratio as a Cardiovascular Risk Marker in a Mexican Urban Middle-Class Population: Do We Need a Risk Score Tailored for Mexicans? J Clin Med. 2023;12(18):6005. Doi: https://doi.org/10.3390/jcm12186005 PMid:37762944 PMCid:PMC10531773
Hajian-Tilaki K, Heidari B, Bakhtiari A. Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholestrol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: Evidence from a population-based cross-sectional study. Casp J Intern Med. 2020;11(1). doi:10.22088/cjim.11.1.53
Ghodsi S, Meysamie A, Abbasi M, et al. Non-high-density lipoprotein fractions are strongly associated with the presence of metabolic syndrome independent of obesity and diabetes: a population-based study among Iranian adults. J Diabetes Metab Disord. 2017;16(1):25. Doi: https://doi.org/10.1186/s40200-017-0306-6 PMid:28596946 PMCid:PMC5463311
Flores-Guerrero JL, Been RA, Shalaurova I, Connelly MA, Van Dijk PR, Dullaart RPF. Triglyceride/HDL cholesterol ratio and lipoprotein insulin resistance Score: Associations with subclinical atherosclerosis and incident cardiovascular disease. Clin Chim Acta. 2024;553:117737. Doi: https://doi.org/10.1016/j.cca.2023.117737 PMid:38142802
Di Pino A, DeFronzo RA. Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents. Endocr Rev. 2019;40(6):1447-1467. Doi: https://doi.org/10.1210/er.2018-00141 PMid:31050706 PMCid:PMC7445419
Williams DR. Racial/Ethnic Variations in Women's Health: The Social Embeddedness of Health. Am J Public Health. 2002;92(4):588-597. Doi: https://doi.org/10.2105/AJPH.92.4.588 PMid:11919058 PMCid:PMC1447123
Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021;69(11):2932. Doi: https://doi.org/10.4103/ijo.IJO_1627_21 PMid:34708726 PMCid:PMC8725109
Wells JCK, Pomeroy E, Walimbe SR, Popkin BM, Yajnik CS. The Elevated Susceptibility to Diabetes in India: An Evolutionary Perspective. Front Public Health. 2016;4. Doi: https://doi.org/10.3389/fpubh.2016.00145 PMid:27458578 PMCid:PMC4935697
Joseph A, Thirupathamma M, Mathews E, Alagu M. Genetics of type 2 diabetes mellitus in Indian and Global Population: A Review. Egypt J Med Hum Genet. 2022;23(1):135. Doi: https://doi.org/10.1186/s43042-022-00346-1 PMid:37192883 PMCid:PMC9438889
Kumar GS, Kulkarni M, Rathi N. Evolving Food Choices Among the Urban Indian Middle-Class: A Qualitative Study. Front Nutr. 2022;9:844413. Doi: https://doi.org/10.3389/fnut.2022.844413 PMid:35425799 PMCid:PMC9001910
Hurt RT, Kulisek C, Buchanan LA, McClave SA. The obesity epidemic: challenges, health initiatives, and implications for gastroenterologists. Gastroenterol Hepatol. 2010;6(12):780-792.
Hu FB. Globalization of Diabetes. Diabetes Care. 2011;34(6):1249-1257. Doi: https://doi.org/10.2337/dc11-0442 PMid:21617109 PMCid:PMC3114340
Martins FO, Conde SV. Impact of Diet Composition on Insulin Resistance. Nutrients. 2022;14(18):3716. Doi: https://doi.org/10.3390/nu14183716 PMid:36145093 PMCid:PMC9505491
Huang X, Liu G, Guo J, Su Z. The PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018;14(11):1483-1496. Doi: https://doi.org/10.7150/ijbs.27173 PMid:30263000 PMCid:PMC6158718
Widmer RJ, Flammer AJ, Lerman LO, Lerman A. The Mediterranean Diet, its Components, and Cardiovascular Disease. Am J Med. 2015;128(3):229-238. Doi: https://doi.org/10.1016/j.amjmed.2014.10.014 PMid:25447615 PMCid:PMC4339461
Weickert MO. Nutritional Modulation of Insulin Resistance. Scientifica. 2012;2012:1-15. Doi: https://doi.org/10.6064/2012/424780 PMid:24278690 PMCid:PMC3820526
Burkitt D. Food fiber and disease prevention. Compr Ther. 1975;1(5):19-22.
Kosmas CE, Rodriguez Polanco S, Bousvarou MD, et al. The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease. Diagnostics. 2023;13(5):929. Doi: https://doi.org/10.3390/diagnostics13050929 PMid:36900073 PMCid:PMC10001260
Semenkovich CF. Insulin resistance and atherosclerosis. J Clin Invest. 2006;116(7):1813-1822. Doi: https://doi.org/10.1172/JCI29024 PMid:16823479 PMCid:PMC1483180
Razani B, Chakravarthy MV, Semenkovich CF. Insulin Resistance and Atherosclerosis. Endocrinol Metab Clin North Am. 2008;37(3):603-621. Doi: https://doi.org/10.1016/j.ecl.2008.05.001 PMid:18775354 PMCid:PMC2639785
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Khalid Khan, Sabiha Quazi, Anil Wanjari
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.